Xencor reported 29.92 in PE Price to Earnings for its fiscal quarter ending in September of 2022.





Pe Change Date
AbbVie 23.45 0.51 Sep/2026
Alnylam Pharmaceuticals 13.17 62.47 Sep/2026
Amgen 18.6 0.53 Sep/2026
Arrowhead Research 39.19 0 Jun/2026
AstraZeneca 24.63 0.71 Sep/2026
Biogen 29.15 5.92 Sep/2026
Bristol-Myers Squibb 10.44 5.7 Sep/2026
GlaxoSmithKline 9.72 0.9 Sep/2026
J&J 25.86 3.57 Sep/2026
Merck 34.36 2.11 Sep/2026
Novartis 19.17 3.24 Sep/2026
Pfizer 15.2 3.72 Sep/2026
Regeneron Pharmaceuticals 15.46 9.68 Jun/2026
Roche Holding 16.48 0.39 Jun/2026
Xencor 29.92 3.22 Sep/2022